This MedLibrary.org supplementary page on Alkylating antineoplastic agent is provided directly from the open source Wikipedia as a service to our readers. Please see the note below on authorship of this content, as well as the Wikipedia usage guidelines. To search for other content from our encyclopedia supplement, please use the form below:
Related Sponsors
An alkylating antineoplastic agent is an alkylating agent that attaches an alkyl group to DNA.
Since cancer cells generally proliferate unrestrictively more than healthy cells do, cancer cells are more sensitive to DNA damage - such as being alkylated. Alkylating agents are used clinically to treat a variety of tumours.
Contents |
Agents acting nonspecifically
Some alkylating agents are active under conditions present in cells; and the same mechanism that makes them toxic allows them to be used as anti-cancer drugs. They stop tumour growth by cross-linking guanine nucleobases in DNA double-helix strands - directly attacking DNA. This makes the strands unable to uncoil and separate. As this is necessary in DNA replication, the cells can no longer divide. These drugs act nonspecifically.
Agents require activation
Some of them require conversion into active substances in vivo (e.g. cyclophosphamide).
Cyclophosphamide is one of the most potent immunosuppressive substances. In small dosages, it is very efficient in the therapy of systemic lupus erythematosus, autoimmune hemolytic anemias, Wegener's granulomatosis and other autoimmune diseases. High dosages cause pancytopenia and hemorrhagic cystitis.
Dialkylating agents, limpet attachment, and monoalkylating agents
Dialkylating agents can react with two different 7-N-guanine residues and if these are in different strands of DNA the result is cross-linkage of the DNA strands, which prevents uncoiling of the DNA double helix. If the two guanine residues are in the same strand the result is called limpet attachment of the drug molecule to the DNA.
Monoalkylating agents can react only with one 7-N of guanine.
Limpet attachment and monoalkylation do not prevent the separation of the two DNA strands of the double helix but do prevent vital DNA processing enzymes from accessing the DNA. The final result is inhibition of cell growth or stimulation of apoptosis, cell suicide.
Examples
In the Anatomical Therapeutic Chemical Classification System, alkylating agents are classified under L01A.
Alkylating agents activated by cytochrome p-450:
- Alkyl sulfonates
- Ethyleneimines and methylmelamines
- Hexamethylmelamine or altretamine (L01)
- Thiotepa (L01)
- Nitrogen mustards
- Cyclophosphamide (L01)
- Mechlorethamine or mustine (L01)
- Uramustine or uracil mustard (no ATC code, PubChem 6194, DrugBank APRD00130)
- Melphalan (L01)
- Chlorambucil (L01)
- Ifosfamide (L01)
- Nitrosoureas
- Carmustine (L01)
- Streptozocin (L01)
- Triazenes
- Imidazotetrazines
- Platinum-based chemotherapeutic drugs (termed platinum analogues) destroy cells by alkylation. These include:
External links
Wikipedia content modification information:
- This page was last modified on 7 September 2008, at 21:06.
Wikipedia Authorship and Review
Wikipedia content provided here is not reviewed directly by MedLibrary.org. Wikipedia content is authored by an open community of volunteers and is not produced by or in any way affiliated with MedLibrary.org.
Wikipedia Usage Guidelines
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article on "Alkylating antineoplastic agent".
The URL for this specific entry is:
All Wikipedia text is available under the terms of the GNU Free Documentation License. (See Copyrights for details). Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc.